Filtrar :
| Norma o proyecto bajo la responsabilidad directa de ISO/TC 276/SC 1 Secretaría | Etapa | ICS |
|---|---|---|
|
Biotechnology — Inventory of methods for detection of microbiological contamination in mammalian cell culture
|
60.60 | |
|
Biotechnology — Genome editing — Part 1: Vocabulary
|
90.92 | |
|
Biotechnology — Genome editing — Part 1: Vocabulary — Amendment 1
|
60.60 | |
|
ISO/AWI 5058-1 [En desarrollo]
Biotechnology — Genome editing — Part 1: Vocabulary
|
20.00 |
|
|
Biotechnology — Cell viability analytical methods — Part 1: General requirements and considerations
|
60.60 | |
|
ISO/CD 8934-2 [En desarrollo]
Biotechnology --Cell viability analytical methods — Part 2: Experimental Designs and Statistical Analysis for Evaluating the Quality of Cell Count-Based Viability Methods
|
30.60 |
|
|
ISO/WD 12833 [En desarrollo]
Biotechnology — Requirements for RNA quantification methods for gene expression analysis of biological and bioengineered systems
|
20.60 |
|
|
Biotechnology — Gene delivery systems — Part 1: Vocabulary
|
60.60 | |
|
Biotechnology — Gene delivery systems — Part 2: Quantification methods for viral vectors
|
60.60 | |
|
ISO/WD 16921-3 [En desarrollo]
Biotechnology — Gene delivery systems — Part 3: Guide for Methods for the Quantification and Characterization of Lipid Nanoparticles
|
20.60 |
|
|
Biotechnology — Cell counting — Part 1: General guidance on cell counting methods
|
90.92 | |
|
ISO 20391-1 [En desarrollo]
Biotechnology — Cell counting — Part 1: General requirements and recommendations for cell counting analytical methods
|
60.00 | |
|
Biotechnology — Cell counting — Part 2: Experimental design and statistical analysis to quantify counting method performance
|
90.93 | |
|
Biotechnology — Requirements for evaluating the performance of quantification methods for nucleic acid target sequences — qPCR and dPCR
|
90.92 | |
|
ISO/CD 20395 [En desarrollo]
Biotechnology — Requirements for evaluating the performance of quantification methods for nucleic acid target sequences — qPCR and dPCR
|
30.60 |
|
|
Biotechnology — Massively parallel sequencing — Part 1: Nucleic acid and library preparation
|
90.92 | |
|
ISO/AWI 20397-1 [En desarrollo]
Biotechnology — NGS — Part 1: Nucleic acid and library preparation
|
10.99 |
|
|
Biotechnology — Massively parallel sequencing — Part 2: Quality evaluation of sequencing data
|
90.92 | |
|
ISO/AWI 20397-2 [En desarrollo]
Biotechnology — NGS — Part 2: Quality evaluation of sequencing data
|
10.99 |
|
|
Biotechnology — Massively parallel sequencing — Part 3: General requirements and guidance for metagenomics
|
90.92 | |
|
ISO/AWI 20397-3 [En desarrollo]
Biotechnology — NGS — Part 3: General requirements and guidance for metagenomics
|
10.99 |
|
|
Biotechnology — Nucleic acid synthesis — Part 1: Requirements for the production and quality control of synthesized oligonucleotides
|
90.93 | |
|
Biotechnology — Nucleic acid synthesis — Part 2: Requirements for the production and quality control of synthesized gene fragments, genes, and genomes
|
60.60 | |
|
ISO/TS 21085 [En desarrollo]
Biotechnology — General requirements for the measurement of ultra-low concentration samples of target nucleic acid sequence
|
60.00 | |
|
ISO/AWI 23033-1 [En desarrollo]
Biotechnology – Cell characterization — Part 1: General requirements and considerations for the testing and characterization of cellular therapeutic products
|
10.99 |
|
|
Biotechnology — Analytical methods — General requirements and considerations for the testing and characterization of cellular therapeutic products
|
90.92 | |
|
ISO 23511 [En desarrollo]
Biotechnology — General requirements and considerations for cell line identification and cross-contamination testing
|
60.00 | |
|
Biotechnology — Analytical methods — Risk-based approach for method selection and validation for rapid microbial detection in bioprocesses
|
60.60 | |
|
Biotechnology — Minimum requirements for optical signal measurements in photometric methods for biological samples
|
60.60 | |
|
Biotechnology — Cellular morphological analysis — General requirements and considerations for cell morphometry to quantify cell morphological features
|
60.60 | |
|
ISO/AWI 25824 [En desarrollo]
General requirements and considerations for cell-mediated cytotoxicity assays used in characterization and testing of CAR products for therapeutic use
|
20.00 |
|
|
ISO/AWI 26012 [En desarrollo]
General Requirements and Considerations for AAV Capsid Content Characterization for Gene Therapy
|
20.00 |
|
|
ISO/WD 26125-1 [En desarrollo]
Biotechnology — Tumorigenicity testing — Part 1: General requirements and considerations for testing of cellular therapeutic products
|
20.60 |
|
No se ha encontrado ningún registro que coincida. Pruebe a cambiar los ajustes de filtro.